Literature DB >> 29807709

Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.

Luisina Martorelli1, Nicolás Garimano2, Gabriela A Fiorentino3, Daniel A Vilte1, Sergio G Garbaccio1, Stefanie A Barth4, Christian Menge4, Cristina Ibarra2, Marina S Palermo3, Angel Cataldi5.   

Abstract

Escherichia coli O157:H7 is a zoonotic pathogen of global importance and the serotype of Shiga toxin-producing E.coli (STEC) most frequently associated with Hemolytic Uremic Syndrome (HUS) in humans. The main STEC reservoir is cattle. Vaccination of calves with the carboxy-terminal fraction of Intimin γ (IntC280) and EspB can reduce E.coli O157:H7 fecal shedding after experimental challenge. Shiga toxin (Stx) exerts local immunosuppressive effects in the bovine intestine and Stx2B fused to Brucella lumazine synthase (BLS-Stx2B) induces Stx2-neutralizing antibodies. To determine if an immune response against Stx could improve a vaccine's effect on fecal shedding, groups of calves were immunized with EspB + IntC280, with EspB + IntC280 + BLS-Stx2B, or kept as controls. At 24 days post vaccination calves were challenged with E.coli O157:H7. Shedding of E.coli O157:H7 was assessed in recto-anal mucosal swabs by direct plating and enrichment followed by immunomagnetic separation and multiplex PCR. Calves were euthanized 15 days after the challenge and intestinal segments were obtained to assess mucosal antibodies. Vaccination induced a significant increase of IntC280 and EspB specific antibodies in serum and intestinal mucosa in both vaccinated groups. Antibodies against Stx2B were detected in serum and intestinal mucosa of animals vaccinated with 3 antigens. Sera and intestinal homogenates were able to neutralize Stx2 verocytotoxicity compared to the control and the 2-antigens vaccinated group. Both vaccines reduced E.coli O157:H7 shedding compared to the control group. The addition of Stx2B to the vaccine formulation did not result in a superior level of protection compared to the one conferred by IntC280 and EspB alone. It remains to be determined if the inclusion of Stx2B in the vaccine alters E.coli O157:H7 shedding patterns in the long term and after recurrent low dose exposure as occurring in cattle herds.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigens; EHEC; O157:H7; Protection; STEC; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 29807709     DOI: 10.1016/j.vaccine.2018.05.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

2.  Repeated Oral Vaccination of Cattle with Shiga Toxin-Negative Escherichia coli O157:H7 Reduces Carriage of Wild-Type E. coli O157:H7 after Challenge.

Authors:  Smriti Shringi; Haiqing Sheng; Carolyn J Hovde; Thomas E Besser; Andrew A Potter; Scott A Minnich
Journal:  Appl Environ Microbiol       Date:  2021-01-04       Impact factor: 4.792

3.  Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.

Authors:  Aravind Shekar; Shylaja Ramlal; Joseph Kingston Jeyabalaji; Murali Harishchandra Sripathy
Journal:  Med Microbiol Immunol       Date:  2018-09-12       Impact factor: 3.402

4.  Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.

Authors:  Javier I Sanchez-Villamil; Daniel Tapia; Alfredo G Torres
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867

5.  Early immune innate hallmarks and microbiome changes across the gut during Escherichia coli O157: H7 infection in cattle.

Authors:  Mariano Larzábal; Wanderson Marques Da Silva; Anmol Multani; Lucas E Vagnoni; Dadin P Moore; Maia S Marin; Nahuel A Riviere; Fernando O Delgado; Daniel A Vilte; Matias Romero Victorica; Tao Ma; Luo Le Guan; Paola Talia; Angel Cataldi; Eduardo R Cobo
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

Review 6.  Recent Advances in Shiga Toxin-Producing Escherichia coli Research in Latin America.

Authors:  Alfredo G Torres; Maria M Amaral; Leticia Bentancor; Lucia Galli; Jorge Goldstein; Alejandra Krüger; Maricarmen Rojas-Lopez
Journal:  Microorganisms       Date:  2018-09-28

7.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

Review 8.  The Role of Escherichia coli Shiga Toxins in STEC Colonization of Cattle.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-09-21       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.